标题

标题

  • Home
  • About Us
    • Company Introduction
    • Team Introduction
    • Quality System
    • Contact Us
  • Process Development
    • Process Development and Optimization
    • Analytical Method Development and Validation
    • Stability studies
    • Formulation and aseptic filling, lyophilization
  • Oligo Manufacturing
    • Preclinical Development, Research-Grade
    • Clinical Phase I-III Production
    • Early Commercial Phase
    • GMP Compliance
    • GMP Facilities and Equipment
    • EHS System
    • Collaborations
    • Case Study
  • Other Service
    • IND Application Dossiers
    • The Melting Temperature (Tm) Test
    • Formulation Development and Production
EN
CN

News

Get up to date with the latest HitGen articles and join us in the events

News
Press Release
Coverage
Events
Industry News
News
标题

标题

In February 2022, HitGen Inc. signed an agreement with Eli Lilly and ConfometRx to begin work on a GPCR target.

Release time:2022-03-21

Previous: HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets
Next: Lipigon and HitGen announce achievement of an important milestone in dyslipidemia project
Home / News / Press Release / In February 2022, HitGen Inc. signed an agreement with Eli Lilly and ConfometRx to begin work on a GPCR target.
首页 Created with Sketch. Home
邮箱1 Created with Sketch. E-mail
电话 Created with Sketch. Tel
标题

标题

Email
info@bd.hitston.com
Tel
+86 (28) 8519 7385
Address
No.9 Lekang Road, Tianfu Internaltional Bio-Town, Shangliu District, Chengdu, Sichuan Province, China 610200

About Us

Company Introduction
Team Introduction
Quality System
Contact Us

Process Development

Process Development and Optimization
Analytical Method Development and Validation
Stability studies
Formulation and aseptic filling, lyophilization

Oligo Manufacturing

Preclinical Development, Research-Grade
Clinical Phase I-III Production
Early Commercial Phase
GMP Compliance
GMP Facilities and Equipment
EHS System
Collaborations
Case Study

Other Service

IND Application Dossiers
The Melting Temperature (Tm) Test
Formulation Development and Production
Copyright © 2025 Hitston Ltd.
Privacy Policy
Terms And Conditions
Powered by iglobalwin.com